|
|
||||||||
New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts
Correspondence: For reprints contact: Mrinal K. Dewanjee, Dept. of Radiology, Div. of Nuclear Medicine, Proger 4, Tufts-New England Medical Center Hospitals, Boston, Mass. 02111.
ABSTRACT
The mechanism and preferential site of binding of 99mTc ion to hemoglobin had been determined by the separation of 99mTc-hemoglobin from 99mTc-citrate and 99mTc-pertechnetate ion with a Sephadex G25 column. This purified fraction was analyzed by the HCl/acetone mixture to determine the 99mTc activity distribution with heme and globin. Most of the 99mTc activity is associated with globin fraction. The preferred chain for 99mTc ion binding was determined by the splitting of 99mTc-hemoglobin with parachloromercuribenzoate solution followed by separation with a diethylaminoethyl cellulose column equilibrated with phosphate buffer. The 99mTc ion, like Cr3+ ion, tends to bind preferentially with the beta chain of hemoglobin.
This article has been cited by other articles:
![]() |
E. G. McFarland, B. F. Morrey, K. N. An, and M. B. Wood The relationship of vascularity and water content to tensile strength in a patellar tendon replacement of the anterior cruciate in dogs Am. J. Sports Med., December 1, 1986; 14(6): 436 - 448. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |